SPAC Feed

Delray Beach, FL, Aug. 21, 2026 (GLOBE NEWSWIRE) — The global Glycolic Acid Market is projected to grow from USD 0.47 billion in 2026 to USD 0.70 billion by 2032, at a CAGR of 6.9% during the forecast period. Growth is driven by increasing demand for glycolic acid in cosmetics, personal care, dermatology, industrial cleaning, household products, and other applications. Rising consumer spending on skincare products, growing demand for anti-aging and anti-pollution formulations, and increasing use of glycolic acid as an effective exfoliating and keratolytic agent are further supporting market growth.

The U.S. category management software market is projected to grow from $0.75 billion in 2025 to $1.99 billion by 2035, while Europe is expected to expand from $0.74 billion to $1.92 billion by 2035, driven by retail digitization, AI-powered analytics, omnichannel strategies, demand forecasting, and increasing adoption of data-driven assortment and pricing solutions.

The U.S. category management software market is projected to grow from $0.75 billion in 2025 to $1.99 billion by 2035, while Europe is expected to expand from $0.74 billion to $1.92 billion by 2035, driven by retail digitization, AI-powered analytics, omnichannel strategies, demand forecasting, and increasing adoption of data-driven assortment and pricing solutions.

U.S. Polylactic Acid (PLA) Market to Hit USD 1.95 Billion by 2035, While Europe Reaches USD 1.86 Billion Amid Rising Sustainable Packaging Demand

U.S. Polylactic Acid (PLA) Market to Hit USD 1.95 Billion by 2035, While Europe Reaches USD 1.86 Billion Amid Rising Sustainable Packaging Demand

The U.S. sovereign cloud market is projected to grow from $38.15 billion in 2025 to $518.62 billion by 2035, while Europe is expected to expand from $31.19 billion to $465.00 billion, driven by data localization laws, GDPR and EU AI act requirements, federal cloud security standards, and rising demand for greater jurisdictional control over sensitive data.

The U.S. sovereign cloud market is projected to grow from $38.15 billion in 2025 to $518.62 billion by 2035, while Europe is expected to expand from $31.19 billion to $465.00 billion, driven by data localization laws, GDPR and EU AI act requirements, federal cloud security standards, and rising demand for greater jurisdictional control over sensitive data.

Dubai, United Arab Emirates, Aug. 21, 2026 (GLOBE NEWSWIRE) — FP Trading, an international forex and CFD brokerage, has confirmed that it now holds a Category 5 licence issued by the UAE’s Capital Market Authority (CMA), formerly the Securities and Commodities Authority (SCA), extending its regulatory footprint into the country on an onshore basis. The licence covers marketing, promotional, and client introduction activity within the UAE.

Hong Kong, Aug. 21, 2026 (GLOBE NEWSWIRE) — NFT Ltd. (NYSE American: MI) (“Company” or “NFT”, formerly known as Takung Art Co., Ltd.), as an emerging online trading platform operator of international art and collectibles, today announced the pricing of its registered offering of 437,957 units (each, a “Unit”), on a best efforts basis, at an offering price of US$4.60 per Unit (the “Offering”).

Kylo Peptides publishes The State of Research Peptides 2026, examining market data, regulation, and the quality gap in the research peptide market.

Appointments enhance governance and strategic oversight as Space-Eyes prepares to operate as a publicly traded company following proposed business combination with McKinley Acquisition Corp.

Appointments enhance governance and strategic oversight as Space-Eyes prepares to operate as a publicly traded company following proposed business combination with McKinley Acquisition Corp.

The U.S. Hemodynamic Monitoring Devices Market to reach USD 0.89 Billion and Europe USD 0.71 Billion by 2035, supported by expanding ICU capacity, rising surgical volumes, and growing adoption of AI-enabled, predictive and non-invasive monitoring technologies.

The U.S. Hemodynamic Monitoring Devices Market to reach USD 0.89 Billion and Europe USD 0.71 Billion by 2035, supported by expanding ICU capacity, rising surgical volumes, and growing adoption of AI-enabled, predictive and non-invasive monitoring technologies.

The U.S. Hemodynamic Monitoring Devices Market to reach USD 0.89 Billion and Europe USD 0.71 Billion by 2035, supported by expanding ICU capacity, rising surgical volumes, and growing adoption of AI-enabled, predictive and non-invasive monitoring technologies.

The U.S. Hemodynamic Monitoring Devices Market to reach USD 0.89 Billion and Europe USD 0.71 Billion by 2035, supported by expanding ICU capacity, rising surgical volumes, and growing adoption of AI-enabled, predictive and non-invasive monitoring technologies.

Owings Mills, MD, Aug. 21, 2026 (GLOBE NEWSWIRE) — Chesapeake Fine Food Group, LLC, parent company of Mackenzie Limited and Chesapeake Bay Crab Cakes and More, announced today the acquisition of Harrington’s of Vermont, the premium purveyor of gourmet smoked hams and meats whose recipes and smokehouse traditions have graced American tables for over 153 years.

MicroCloud Hologram Inc. Announces Acquisition of 140,268 MSTR Shares Through Structured Note Investment Product

QXL’s updated AI-driven decoder demonstrated improved performance supporting the Company’s roadmap toward reliable fault-tolerant quantum computing

Dallas, TX, Aug. 21, 2026 (GLOBE NEWSWIRE) — Vivakor, Inc. (Nasdaq: VIVK) (“Vivakor” or the “Company”), an integrated provider of energy transportation, storage, reuse and remediation services, today announced financial results for the three and six months ended June 30, 2026, highlighted by second-quarter revenue growth, a 45% increase in second-quarter gross profit and a return to positive operating income.

Acquisition adds multi-state direct lending with in-house underwriting and funding, expanding reAlpha’s integrated mortgage platform across 38 states and Washington, D.C.

Acquisition adds multi-state direct lending with in-house underwriting and funding, expanding reAlpha’s integrated mortgage platform across 38 states and Washington, D.C.

WALTHAM, Mass. and SAN DIEGO, Aug. 21, 2026 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (Nasdaq: HOWL) and Ambros Therapeutics, Inc., today announced that they entered into a definitive merger agreement to combine the companies in an all-stock transaction. The combined company will focus on advancing Ambros Therapeutics’ neridronate development program in Complex Regional Pain Syndrome Type 1 (“CRPS-1”, formerly known as Reflex Sympathetic Dystrophy). Upon completion of the merger, the combined company will operate as Ambros Therapeutics, headquartered in San Diego, California, and is expected to trade under the Nasdaq ticker symbol “AMBX”.

WALTHAM, Mass. and SAN DIEGO, Aug. 21, 2026 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (Nasdaq: HOWL) and Ambros Therapeutics, Inc., today announced that they entered into a definitive merger agreement to combine the companies in an all-stock transaction. The combined company will focus on advancing Ambros Therapeutics’ neridronate development program in Complex Regional Pain Syndrome Type 1 (“CRPS-1”, formerly known as Reflex Sympathetic Dystrophy). Upon completion of the merger, the combined company will operate as Ambros Therapeutics, headquartered in San Diego, California, and is expected to trade under the Nasdaq ticker symbol “AMBX”.

Company explores additional growth opportunities, including the possible acquisition of AI-Based Technologies, Cybersecurity or Data Centers, while continuing its existing business activities

U.S. Market to Hit USD 2.86 Billion and Europe USD 2.52 Billion by 2035 as Detergent Demand and Biodegradable Surfactant Use Support Growth

U.S. Market to Hit USD 2.86 Billion and Europe USD 2.52 Billion by 2035 as Detergent Demand and Biodegradable Surfactant Use Support Growth